Accessed August 17, 2023.
The study followed a qualitative design based on semi-structured interviews
Semaglutide is also available as injectable formulations, including Ozempic and Wegovy , which are widely recognized for their efficacy in the management of T2DM and obesity
Patients who reach the maintenance phase and sustain it over 24 to 36 weeks have reported total body weight reductions ranging from 15% to upwards of 24% in some cases
Gastrointestinal disorders, primarily nausea, were the most common treatment-emergent adverse events, which could be mitigated with slower dose escalation
GLP-1 medications mimic the natural action of the gut hormone glucagon-like peptide-1 (GLP-1), which regulates blood sugar levels and appetite